Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
1.
PLoS One ; 18(1): e0279873, 2023.
Article in English | MEDLINE | ID: mdl-36602973

ABSTRACT

BACKGROUND: Conflicting results are reported about daytime variation on mortality and cardiac outcomes after non-cardiac surgeries. In this cohort study, we evaluate whether the period of the day in which surgeries are performed may influence all-cause mortality and cardiovascular outcomes in patients undergoing non-cardiac arterial vascular procedures. METHODS: 1,267 patients who underwent non-cardiac arterial vascular surgeries between 2012 and 2018 were prospectively included in our cohort and categorized into two groups: morning (7 a.m. to 12 a.m., 79%) and afternoon/night (12:01 p.m. to 6:59 a.m. in the next day, 21%) surgeries. Primary endpoint was all-cause mortality within 30 days and one year. Secondary endpoints were the incidence of perioperative myocardial injury/infarction (PMI), and the incidence of major adverse cardiac events (MACE, including acute myocardial infarction, acute heart failure, arrhythmias, cardiovascular death) at hospital discharge. RESULTS: After adjusting for confounders in the multivariable Cox proportional regression, all-cause mortality rates at 30 days and one year were higher among those who underwent surgery in the afternoon/night (aHR 1.6 [95%CI 1.1-2.3], P = 0.015 and aHR 1.7 [95%CI 1.3-2.2], P < 0.001, respectively). Afternoon/night patients had higher incidence of PMI (aHR 1.4 [95%CI 1.1-1.7], P < 0.001). There was no significant difference in the incidence of MACE (aHR 1.3 [95%CI 0.9-1.7], P = 0.074). CONCLUSIONS: In patients undergoing arterial vascular surgery, being operated in the afternoon/night was independently associated with increased all-cause mortality rates and incidence of perioperative myocardial injury/infarction.


Subject(s)
Heart Diseases , Myocardial Infarction , Humans , Cohort Studies , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Myocardial Infarction/etiology , Vascular Surgical Procedures/adverse effects , Risk Factors
2.
BMC Med ; 20(1): 374, 2022 10 26.
Article in English | MEDLINE | ID: mdl-36284318

ABSTRACT

BACKGROUND: Observational studies support a role for oral anticoagulation to reduce the risk of dementia in atrial fibrillation patients, but conclusive data are lacking. Since dabigatran offers a more stable anticoagulation, we hypothesized it would reduce cognitive decline when compared to warfarin in old patients with atrial fibrillation. METHODS: The GIRAF trial was a 24-month, randomized, parallel-group, controlled, open-label, hypothesis generating trial. The trial was done in six centers including a geriatric care unit, secondary and tertiary care cardiology hospitals in São Paulo, Brazil. We included patients aged ≥ 70 years and CHA2DS2-VASc score > 1. The primary endpoint was the absolute difference in cognitive performance at 2 years. Patients were assigned 1:1 to take dabigatran (110 or 150 mg twice daily) or warfarin, controlled by INR and followed for 24 months. Patients were evaluated at baseline and at 2 years with a comprehensive and thorough cognitive evaluation protocol of tests for different cognitive domains including the Montreal Cognitive Assessment (MoCA), Mini-Mental State Exam (MMSE), a composite neuropsychological test battery (NTB), and computer-generated tests (CGNT). RESULTS: Between 2014 and 2019, 5523 participants were screened and 200 were assigned to dabigatran (N = 99) or warfarin (N = 101) treatment. After adjustment for age, log of years of education, and raw baseline score, the difference between the mean change from baseline in the dabigatran group minus warfarin group was - 0.12 for MMSE (95% confidence interval [CI] - 0.88 to 0.63; P = 0.75), 0.05 (95% CI - 0.07 to 0.18; P = 0.40) for NTB, - 0.15 (95% CI - 0.30 to 0.01; P = 0.06) for CGNT, and - 0.96 (95% CI - 1.80 to 0.13; P = 0.02) for MoCA, with higher values suggesting less cognitive decline in the warfarin group. CONCLUSIONS: For elderly patients with atrial fibrillation, and without cognitive compromise at baseline that did not have stroke and were adequately treated with warfarin (TTR of 70%) or dabigatran for 2 years, there was no statistical difference at 5% significance level in any of the cognitive outcomes after adjusting for multiple comparisons. TRIAL REGISTRATION: Cognitive Impairment Related to Atrial Fibrillation Prevention Trial (GIRAF), NCT01994265 .


Subject(s)
Atrial Fibrillation , Stroke , Aged , Humans , Warfarin/adverse effects , Dabigatran/adverse effects , Atrial Fibrillation/drug therapy , Atrial Fibrillation/complications , Anticoagulants/adverse effects , Brazil/epidemiology , Stroke/complications , Cognition
5.
Arq Bras Cardiol ; 109(3 Supl 1): 1-104, 2017.
Article in English, Portuguese | MEDLINE | ID: mdl-29044300
6.
Arq. bras. cardiol ; 109(3,supl.1): 1-104, Sept. 2017. tab, graf
Article in English | LILACS | ID: biblio-887936
7.
Intern Emerg Med ; 9(2): 133-42, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24057347

ABSTRACT

Stroke is one of the most important causes of mortality and morbidity worldwide and, for a long time, was the leading cause of death in developed countries. Atherothrombotic carotid stenosis is one of the most important etiologies behind this event. If properly recognized and treated, lives can be saved, as well as long-term disabilities prevented. With population aging and improvements in surgical and clinical care, patients with several comorbidities will be referred for revascularization procedures more frequently, posing a challenge for physicians. The purpose of this review is to provide internists and clinicians with information based on several studies so they can offer to their patients, the best evidence-based care, indicating appropriate medical therapy, as well as referral to a vascular surgeon, or what contraindicates endarterectomy or angioplasty, depending on individual characteristics.


Subject(s)
Carotid Stenosis/diagnosis , Carotid Stenosis/surgery , Humans , Internal Medicine , Vascular Surgical Procedures/methods
8.
J Vasc Surg ; 58(6): 1593-9, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24280324

ABSTRACT

INTRODUCTION: Vascular surgeries are related to high cardiac morbidity and mortality, and the maintenance of aspirin in the perioperative period has a protective effect. The purpose of this study was to evaluate the association between preoperative platelet aggregability and perioperative cardiovascular (CV) events. METHODS: A preoperative platelet aggregation test was performed on an impedance aggregometer in response to collagen and to arachidonic acid (AA) for 191 vascular surgery patients under chronic use of aspirin. We analyzed the following CV events: acute myocardial infarction, unstable angina, isolated troponin elevation, acute ischemic stroke, reoperation, and cardiac death. Hemorrhagic events were also evaluated and classified according to the Thrombolysis In Myocardial Infarction criteria. RESULTS: The incidence of CV events was 22% (n = 42). Higher platelet response to AA was associated with CV events, so that patients in the fourth quartile (higher than 11Ω) had almost twice the incidence of CV events when compared with the three lower quartiles: 35% vs 19%; P = .025. The independent predictors of CV events were hemodynamic instability during anesthesia (odds ratio [OR], 4.12; 95% confidence interval [CI], 1.87-9.06; P < .001), dyslipidemia (OR, 3.9; 95% CI, 1.32-11.51; P = .014), preoperative anemia (OR, 2.64; 95% CI, 1.19-5.85; P = .017), and AA platelet aggregability in the upper quartile (OR, 2.48; 95% CI, 1.07-5.76; P = .034). Platelet aggregability was not associated with hemorrhagic events, even when we compared the lowest quartile of AA platelet aggregability (0-1.00 Ω) with the three upper quartiles (>1.00 Ω; OR, 0.77; 95% CI, 0.43-1.37; P = .377). CONCLUSIONS: The degree of aspirin effect on platelet aggregability maybe important in the management of perioperative CV morbidity, without increment in the bleeding toll.


Subject(s)
Aspirin/administration & dosage , Cardiovascular Diseases/prevention & control , Perioperative Care/methods , Postoperative Complications , Vascular Surgical Procedures , Aged , Brazil/epidemiology , Cardiovascular Diseases/blood , Cardiovascular Diseases/epidemiology , Dose-Response Relationship, Drug , Female , Follow-Up Studies , Humans , Incidence , Male , Platelet Aggregation/drug effects , Platelet Aggregation Inhibitors/administration & dosage , Prognosis , Retrospective Studies , Survival Rate/trends
10.
Arq Bras Cardiol ; 99(5): 1060-7, 2012 Nov.
Article in English, Portuguese | MEDLINE | ID: mdl-23138671

ABSTRACT

Over 230 million surgeries are performed annually worldwide, cardiac complications being the most common causes of postoperative morbidity and mortality. As life expectancy has extended worldwide, a growing number of patients with multiple comorbidities have undergone noncardiac surgeries. Consequently, cardiovascular complications associated with those procedures are expected to increase, and perioperative acute myocardial infarction (AMI) might become a frequent problem. In Brazil, the number of noncardiac surgical procedures has also increased, and approximately three million surgeries are performed annually. Despite advances in surgical and anesthetic techniques, mortality and costs related to those procedures have also increased, thus, requiring the development of strategies to reduce mortality(4). The occurrence of perioperative AMI prolongs the need for intensive care and the hospital length of stay, increases the cost of hospitalization, and reduces long-term survival. This literature review approaches the pathophysiology, incidence, diagnosis and treatment of perioperative AMI based on current evidence.


Subject(s)
Intraoperative Complications/physiopathology , Myocardial Infarction/physiopathology , Humans , Myocardial Infarction/diagnosis , Myocardial Infarction/therapy , Risk Factors
11.
Arq. bras. cardiol ; 99(5): 1060-1067, nov. 2012. ilus
Article in Portuguese | LILACS | ID: lil-656643

ABSTRACT

Em todo o mundo, são realizadas mais de 230 milhões de operações por ano e as complicações cardíacas são as causas mais comuns de morbidade e mortalidade pós-operatórias. Com o aumento da expectativa de vida da população mundial, um número crescente de pacientes com múltiplas comorbidades tem sido submetido a operações não cardíacas. Em consequência, é esperado um aumento de complicações cardiovasculares associadas a tais procedimentos e o infarto agudo do miocárdio (IAM) perioperatório poderá se tornar um problema frequente. No Brasil, o número de operações não cardíacas também está aumentando, sendo realizadas aproximadamente três milhões de cirurgias por ano. Apesar dos avanços nas técnicas cirúrgicas e anestésicas, a mortalidade e o custo relacionados a estes procedimentos também estão aumentando, sendo fundamental o desenvolvimento de estratégias para a redução da mortalidade. A ocorrência de um IAM perioperatório prolonga a necessidade de terapia intensiva, a estadia hospitalar, aumenta o custo da internação e diminui a sobrevida a longo prazo. Esta revisão aborda a fisiopatologia, a incidência, o diagnóstico e o tratamento do IAM perioperatório, baseado nas evidências atuais.


Over 230 million surgeries are performed annually worldwide, cardiac complications being the most common causes of postoperative morbidity and mortality. As life expectancy has extended worldwide, a growing number of patients with multiple comorbidities have undergone noncardiac surgeries. Consequently, cardiovascular complications associated with those procedures are expected to increase, and perioperative acute myocardial infarction (AMI) might become a frequent problem. In Brazil, the number of noncardiac surgical procedures has also increased, and approximately three million surgeries are performed annually. Despite advances in surgical and anesthetic techniques, mortality and costs related to those procedures have also increased, thus, requiring the development of strategies to reduce mortality4. The occurrence of perioperative AMI prolongs the need for intensive care and the hospital length of stay, increases the cost of hospitalization, and reduces long-term survival. This literature review approaches the pathophysiology, incidence, diagnosis and treatment of perioperative AMI based on current evidence.


Subject(s)
Humans , Intraoperative Complications/physiopathology , Myocardial Infarction/physiopathology , Myocardial Infarction/diagnosis , Myocardial Infarction/therapy , Risk Factors
12.
Atherosclerosis ; 222(1): 191-5, 2012 May.
Article in English | MEDLINE | ID: mdl-22410124

ABSTRACT

PURPOSE: The pathophysiology of acute coronary syndromes (ACS) after noncardiac surgery is not established yet. Thrombosis over a vulnerable plaque or decreased oxygen supply secondary to anemia or hypotension may be involved. The purpose of this study was to investigate the pathophysiology of ACS complicating noncardiac surgery. METHODS: Clinical and angiographic data were prospectively recorded into a database for 120 consecutive patients that had an ACS after noncardiac surgery (PACS), for 120 patients with spontaneous ACS (SACS), and 240 patients with stable coronary artery disease (CAD). Coronary lesions with obstructions greater than 50% were classified based on two criteria: Ambrose's classification and complex morphology. The presence of Ambrose's type II or complex lesions were compared between the three groups. RESULTS: We analyzed 1470 lesions in 480 patients. In PACS group, 45% of patients had Ambrose's type II lesions vs. 56.7% in SACS group and 16.4% in stable CAD group (P<0.001). Both PACS and SACS patients had more complex lesions than patients in stable CAD group (56.7% vs. 79.2% vs. 31.8%, respectively; P<0.001). Overall, the independent predictors of plaque rupture were being in the group PACS (P<0.001, OR 2.86; CI, 1.82-4.52 for complex lesions and P<0.001, OR 3.43; CI, 2.1-5.6 for Ambrose's type II lesions) or SACS (P<0.001, OR 8.71; CI, 5.15-14.73 for complex lesions and P<0.001, OR 5.99; CI, 3.66-9.81 for Ambrose's type II lesions). CONCLUSIONS: Nearly 50% of patients with perioperative ACS have evidence of coronary plaque rupture, characterizing a type 1 myocardial infarction.


Subject(s)
Acute Coronary Syndrome/etiology , Myocardial Infarction/complications , Plaque, Atherosclerotic/complications , Rupture/physiopathology , Surgical Procedures, Operative/adverse effects , Aged , Coronary Artery Disease/complications , Coronary Artery Disease/diagnostic imaging , Female , Humans , Male , Middle Aged , Myocardial Infarction/diagnostic imaging , Plaque, Atherosclerotic/physiopathology , Prospective Studies , Radiography , Rupture/complications
13.
Arq Bras Cardiol ; 96(3 Suppl 1): 1-68, 2011.
Article in English, Portuguese | MEDLINE | ID: mdl-21655875
14.
Arq. bras. cardiol ; 96(3,supl.1): 1-68, 2011. ilus, tab
Article in Portuguese | LILACS | ID: lil-588887
16.
PLoS One ; 5(5): e10607, 2010 May 12.
Article in English | MEDLINE | ID: mdl-20485549

ABSTRACT

BACKGROUND: Worldwide distribution of surgical interventions is unequal. Developed countries account for the majority of surgeries and information about non-cardiac operations in developing countries is scarce. The purpose of our study was to describe the epidemiological data of non-cardiac surgeries performed in Brazil in the last years. METHODS AND FINDINGS: This is a retrospective cohort study that investigated the time window from 1995 to 2007. We collected information from DATASUS, a national public health system database. The following variables were studied: number of surgeries, in-hospital expenses, blood transfusion related costs, length of stay and case fatality rates. The results were presented as sum, average and percentage. The trend analysis was performed by linear regression model. There were 32,659,513 non-cardiac surgeries performed in Brazil in thirteen years. An increment of 20.42% was observed in the number of surgeries in this period and nowadays nearly 3 million operations are performed annually. The cost of these procedures has increased tremendously in the last years. The increment of surgical cost was almost 200%. The total expenses related to surgical hospitalizations were more than $10 billion in all these years. The yearly cost of surgical procedures to public health system was more than $1.27 billion for all surgical hospitalizations, and in average, U$445.24 per surgical procedure. The total cost of blood transfusion was near $98 million in all years and annually approximately $10 million were spent in perioperative transfusion. The surgical mortality had an increment of 31.11% in the period. Actually, in 2007, the surgical mortality in Brazil was 1.77%. All the variables had a significant increment along the studied period: r square (r(2)) = 0.447 for the number of surgeries (P = 0.012), r(2) = 0.439 for in-hospital expenses (P = 0.014) and r(2) = 0.907 for surgical mortality (P = 0.0055). CONCLUSION: The volume of surgical procedures has increased substantially in Brazil through the past years. The expenditure related to these procedures and its mortality has also increased as the number of operations. Better planning of public health resource and strategies of investment are needed to supply the crescent demand of surgery in Brazil.


Subject(s)
Developing Countries/economics , Surgical Procedures, Operative/economics , Brazil , Cardiac Surgical Procedures/economics , Cardiac Surgical Procedures/trends , Depreciation , Humans , Perioperative Care , Surgical Procedures, Operative/trends , Time Factors
19.
São Paulo; s.n; 2010. 114 p.
Thesis in Portuguese | LILACS | ID: lil-579509

ABSTRACT

Anualmente são realizadas mais de 234 milhões de cirurgias no mundo com taxas de morbi e mortalidade relativamente elevadas. Os dados nacionais disponíveis de registros de operações não cardíacas são escassos e deficientes. O objetivo do nosso estudo foi avaliar o perfil epidemiológico dos pacientes submetidos a operações não cardíacas e a sua evolução nos últimos anos no Brasil. Selecionamos a partir do banco de dados de DATASUS, as informações de sistema público de saúde em caráter nacional para descrição epidemiológica de operações não cardíacas realizadas no país. As variáveis estudadas foram: número total de internações, gasto total por internação, gasto com transfusões sanguíneas, número de óbitos e tempo de internação hospitalar. O período estudado compreendeu os anos de 1995 a 2007. No período de 13 anos, foram realizadas 32.659.513 operações não cardíacas no país e houve um incremento de 20,42% no número de procedimentos realizados. De forma semelhante, os gastos hospitalares relacionados a estas cirurgias apresentaram aumento importante neste período (~ 200%), com gasto anual superior a 2 bilhões de reais. As despesas relacionadas às transfusões sanguíneas no perioperatório tiveram um aumento superior a 100%, com um gasto anual acima de 17 milhões de reais ao ano. A mortalidade hospitalar encontrada é bastante elevada no nosso país, com média de 1,77% e o aumento registrado foi mais de 30% no período. A única variável que apresentou redução ao longo dos últimos anos foi o tempo de internação hospitalar, com a média de permanência de 3,83 dias. Concluímos que há uma tendência no aumento de intervenções cirúrgicas no país. Apesar do aumento dos gastos hospitalares relacionados a estas cirurgias, a taxa de mortalidade encontrada ainda é bastante elevada. Estudos futuros são necessários para maior investigação e elaboração de estratégias complementares para melhorar os resultados cirúrgicos.


Worldwide, there were performed about 234 millions of surgeries annually with a relatively high surgical morbidity and mortality. Registry and information about non-cardiac operations in Brazil are scarce and deficient. The purpose of our study was to describe the epidemiological data of non-cardiac surgeries performed in Brazil in the last years. This is a retrospective cohort study that investigated the time-window from 1995 to 2007. We collected information from DATASUS, a national public health system database. The variables studied were: number of surgeries, in-hospital expenses, blood transfusion related costs, length of stay and case fatality rates. There were 32.659.513 non-cardiac surgeries performed in Brazil in thirteen years. An increment of 20.42% was observed in the number of surgeries in this period. The cost of these procedures has increased tremendously in the last years. The increment of surgical cost was almost 200% and the yearly cost of surgical procedures to public health system was superior to 1.2 billions of dollars (2 billions of reais). The cost of blood transfusion had an increment superior to 100% and annually approximately 10 millions of dollars (17 millions of reais) were spent in perioperative transfusion. Actually, in 2007, the surgical mortality in Brazil was 1.77% and it had an increment of 31.11% in the period of 1995 to 2007. The length of stay was the unique variable which had a reduction of its numbers in the period. In average, the mean time of surgical hospitalization was 3.83 days. We concluded that the volume of surgical procedures has increased substantially in Brazil through the past years. The expenditure related to these procedures and its mortality has also increased as the number of operations. Better planning of public health resource and strategies of investment are needed to supply the crescent demand of surgery in Brazil.


Subject(s)
Humans , Economics, Medical , Epidemiology , General Surgery , Morbidity , Mortality , Perioperative Care
SELECTION OF CITATIONS
SEARCH DETAIL
...